CLINICAL_TRIALS
trial_result
· 2024-04-09
Clinical Trial Update: Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating lenalidomide as maintenance therapy in relapsed diffuse large B-cell lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IRCCS San Raffaele | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-04-09